P&G Says Zegerid Switch Proposal Should Drop “Immediate Release” Claim
This article was originally published in The Tan Sheet
Executive Summary
The proton pump inhibitor Zegerid should not be allowed on the over-the-counter market with the label claim "immediate release," says Prilosec OTC marketer Procter & Gamble